{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T06:57:23Z","timestamp":1790578643318,"version":"4.1.0"},"posted":{"date-parts":[[2026,9,28]]},"group-title":"In Review","reference-count":102,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,8,31]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Background\n Insulin signalling is mediated by the\n                  <italic>INSR<\/italic>\n                  -encoded receptor tyrosine kinase. Biallelic\n                  <italic>INSR<\/italic>\n                  variants cause the most severe insulin resistance (IR), whereas heterozygous mutations cause less rare but still severe IR. Dominantly inherited IR has been attributed to dominant negative action of intracellular (IC) missense variants, but whether extracellular (EC) variants exert dominant-negative effects, and whether simple heterozygous loss of function (LoF) causes a metabolic phenotype, remains unresolved. We aimed to clarify the phenotypic spectrum, underlying mechanisms, and natural history of IR caused by heterozygous\n                  <italic>INSR<\/italic>\n                  variants.\nMethods\n We aggregated genetic and clinical data from 505 individuals with monoallelic rare\n                  <italic>INSR<\/italic>\n                  variants from published reports, international referral centres, ClinVar\/HGMD, and the Fenland population cohort. Loss-of-function (LoF) status was assigned using in silico tools including NMDetector and SpliceAI; Insulin concentrations were compared against age-, sex-, and BMI-specific reference centiles (Fenland, NHANES, IDEFICS). The common p.M1180K variant was functionally characterised by assessing cell-surface expression, and insulin-induced autophosphorylation.\nResults\n 240 probands and 265 relatives were studied. There was marked female predominance among probands (Male:Female\u2009=\u20091:3.4) and earlier female presentation, most often with hyperandrogenism. Presentation with diabetes, hyperinsulinaemia, or hypoglycaemia was common in both sexes. Missense variants were 14-fold enriched in the IC domain compared to gnomAD, concentrated in key functional motifs including activation and catalytic loops, whereas LoF variants were distributed in proportion to domain length. The p.M1180K variant was normally expressed but autophosphorylation-deficient. Most EC variant carriers \u2014 including genetically-ascertained individuals with EC LoF or deleterious missense variants \u2014 showed moderate to severe IR from puberty onwards. Across the whole cohort with IC or EC variants, diabetes occurred in 56% and hypoglycaemia in 55%, the latter a presenting feature in 11% of probands and common among relatives. Birthweight standard deviation score (SDS) was reduced (\u20131.0) and BMI SDS modestly increased (+\u20090.7). Hyperandrogenism and\/or Polyendocrine Metabolic Ovarian Syndrome affected 82% of postpubertal females, while GDM affected 20\u201353% of pregnancies. Lipid profiles were normal.\nConclusions\n The human\n                  <italic>INSR<\/italic>\n                  demonstrates haploinsufficiency, with EC LoF and deleterious missense variants causing IR with variable penetrance. Hypoglycaemia is more common than previously recognised, warranting caution with diabetes therapies.\n                <\/p>","DOI":"10.21203\/rs.3.rs-10884175\/v1","type":"posted-content","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T06:37:25Z","timestamp":1790577445000},"source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive assessment of the genotype-phenotype spectrum and treatment for monoallelic insulin receptoropathy in a cohort of 505 people"],"prefix":"10.21203","author":[{"given":"Rebecca","family":"Brown","sequence":"first","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxiang","family":"Xu","sequence":"additional","affiliation":[{"name":"University of Edinburgh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian'an","family":"Luan","sequence":"additional","affiliation":[{"name":"University of Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Donadille","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Aslanzadeh","sequence":"additional","affiliation":[{"name":"University of Edinburgh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bellan\u00e9-Chantelot","sequence":"additional","affiliation":[{"name":"Assistance Publique \u2013 H\u00f4pitaux de Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Grasso","sequence":"additional","affiliation":[{"name":"University of Rome Tor Vergata"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Collin-Chavagnac","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mafalda","family":"Mucciolo","sequence":"additional","affiliation":[{"name":"Bambino Ges\u00f9 Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Allix","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire d'Angers"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bachelot","sequence":"additional","affiliation":[{"name":"Assistance Publique \u2013 H\u00f4pitaux de Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Baron","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Nantes"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danila","family":"Benevento","sequence":"additional","affiliation":[{"name":"Bambino Ges\u00f9 Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Blanco","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Bordeaux"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Bourgeon","sequence":"additional","affiliation":[{"name":"Assistance Publique \u2013 H\u00f4pitaux de Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Christin-Ma\u00eetre","sequence":"additional","affiliation":[{"name":"Assistance Publique \u2013 H\u00f4pitaux de Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Cochran","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Coutant","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire d'Angers"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Dheghani","sequence":"additional","affiliation":[{"name":"Assistance Publique \u2013 H\u00f4pitaux de Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Deodati","sequence":"additional","affiliation":[{"name":"Bambino Ges\u00f9 Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Djakour\u00e9","sequence":"additional","affiliation":[{"name":"Centre Hospitalier de La Rochelle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00e8le","family":"Dubois-Laforgue","sequence":"additional","affiliation":[{"name":"Assistance Publique \u2013 H\u00f4pitaux de Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Duranteau","sequence":"additional","affiliation":[{"name":"Assistance Publique \u2013 H\u00f4pitaux de Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire-Lise","family":"Gay","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri Atma","family":"Greeley","sequence":"additional","affiliation":[{"name":"University of Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00fclay","family":"Guran","sequence":"additional","affiliation":[{"name":"Marmara University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balamurugan","family":"Kandasamy","sequence":"additional","affiliation":[{"name":"University of Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Laloi-Michelin","sequence":"additional","affiliation":[{"name":"Assistance Publique \u2013 H\u00f4pitaux de Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Mahot","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Nantes"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Maiter","sequence":"additional","affiliation":[{"name":"Cliniques Universitaires Saint-Luc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanathan","family":"Mohan","sequence":"additional","affiliation":[{"name":"Dr. Mohan's Diabetes Specialities Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinki","family":"Murphy","sequence":"additional","affiliation":[{"name":"University of Auckland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Nob\u00e9court","sequence":"additional","affiliation":[{"name":"University of Reunion Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Novella","family":"Rapini","sequence":"additional","affiliation":[{"name":"Bambino Ges\u00f9 Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Salenave","sequence":"additional","affiliation":[{"name":"Assistance Publique \u2013 H\u00f4pitaux de Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Shah","sequence":"additional","affiliation":[{"name":"Queen Mary University of London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Startzell","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Tauveron","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Clermont-Ferrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Terral","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Clermont-Ferrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Kemal","family":"Topaloglu","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"V.P.","sequence":"additional","affiliation":[{"name":"Amrita Institute of Medical Sciences and Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Vantyghem","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Lille"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vankatesan","family":"Radha","sequence":"additional","affiliation":[{"name":"Madras Diabetes Research Foundation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wabitsch","sequence":"additional","affiliation":[{"name":"University Hospital Ulm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Winocour","sequence":"additional","affiliation":[{"name":"East and North Hertfordshire NHS Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannele","family":"Yki-J\u00e4rvinen","sequence":"additional","affiliation":[{"name":"University of Helsinki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Young","sequence":"additional","affiliation":[{"name":"Assistance Publique \u2013 H\u00f4pitaux de Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Williams","sequence":"additional","affiliation":[{"name":"Nottingham University Hospitals NHS Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashyap","family":"Patel","sequence":"additional","affiliation":[{"name":"University of Exeter"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Marcovecchio","sequence":"additional","affiliation":[{"name":"University of Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Lebreton","sequence":"additional","affiliation":[{"name":"H\u00f4pital Pellegrin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Vatier","sequence":"additional","affiliation":[{"name":"Assistance Publique \u2013 H\u00f4pitaux de Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Wareham","sequence":"additional","affiliation":[{"name":"University of Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Stears","sequence":"additional","affiliation":[{"name":"NHS National Severe Insulin Resistance Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Bismuth","sequence":"additional","affiliation":[{"name":"Assistance Publique \u2013 H\u00f4pitaux de Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Savage","sequence":"additional","affiliation":[{"name":"University of Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"J\u00e9ru","sequence":"additional","affiliation":[{"name":"Assistance Publique \u2013 H\u00f4pitaux de Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"O'Rahilly","sequence":"additional","affiliation":[{"name":"University of Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Colclough","sequence":"additional","affiliation":[{"name":"Royal Devon University Healthcare NHS Foundation Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Brierley","sequence":"additional","affiliation":[{"name":"Royal Veterinary College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Barbetti","sequence":"additional","affiliation":[{"name":"University of Rome Tor Vergata"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Vigouroux","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Semple","sequence":"additional","affiliation":[{"name":"University of Edinburgh"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0092-8674(85)90334-4","article-title":"The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling","volume":"40","author":"Ebina Y","year":"1985","unstructured":"Ebina Y, Ellis L, Jarnagin K, Edery M, Graf L, Clauser E, et al. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell. 1985;40(4):747\u201358.","journal-title":"Cell"},{"issue":"6005","key":"ref2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/313756a0","article-title":"Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes","volume":"313","author":"Ullrich A","year":"1985","unstructured":"Ullrich A, Bell JR, Chen EY, Herrera R, Petruzzelli LM, Dull TJ, et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature. 1985;313(6005):756\u201361.","journal-title":"Nature"},{"issue":"5875","key":"ref3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/298667a0","article-title":"Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system","volume":"298","author":"Kasuga M","year":"1982","unstructured":"Kasuga M, Zick Y, Blithe DL, Crettaz M, Kahn CR. Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature. 1982;298(5875):667\u20139.","journal-title":"Nature"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"a008946","DOI":"10.1101\/cshperspect.a008946","article-title":"The insulin receptor: both a prototypical and atypical receptor tyrosine kinase","volume":"5","author":"Hubbard SR","year":"2013","unstructured":"Hubbard SR. The insulin receptor: both a prototypical and atypical receptor tyrosine kinase. Cold Spring Harb Perspect Biol. 2013;5(3):a008946.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1083\/jcb.201711047","article-title":"Visualization of ligand-induced transmembrane signaling in the full-length human insulin receptor","volume":"217","author":"Gutmann T","year":"2018","unstructured":"Gutmann T, Kim KH, Grzybek M, Walz T, Coskun \u00dc. Visualization of ligand-induced transmembrane signaling in the full-length human insulin receptor. J Cell Biol. 2018;217(5):1643\u20139.","journal-title":"J Cell Biol"},{"issue":"4853","key":"ref6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.2834824","article-title":"Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance","volume":"240","author":"Kadowaki T","year":"1988","unstructured":"Kadowaki T, Bevins CL, Cama A, Ojamaa K, Marcus-Samuels B, Kadowaki H, et al. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Sci (New York NY). 1988;240(4853):787\u201390.","journal-title":"Sci (New York NY)"},{"key":"ref7","first-page":"784","volume-title":"Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing","author":"Yoshimasa Y","year":"1988","unstructured":"Yoshimasa Y, Seino S, Whittaker J, Kakehi T, Kosaki A, Kuzuya H, et al. Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing. Volume 240. New York, NY: Science; 1988. pp. 784\u20137. 4853."},{"key":"ref8","author":"Taylor SI","year":"1992","unstructured":"Taylor SI, Cama A, Accili D, Barbetti F, Quon MJ. de la Luz Sierra M, Mutations in the insulin receptor gene. Endocrine reviews. 1992;13(3):566\u2009\u2013\u200995."},{"key":"ref9","volume-title":"INSR-Related Severe Insulin Resistance Syndrome","author":"Mesika A","year":"2018","unstructured":"Mesika A, Klar A, Falik Zaccai TC. INSR-Related Severe Insulin Resistance Syndrome. GeneReviews\u00ae [Internet]: University of Washington, Seattle; 2018."},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2337\/diacare.13.6.576","article-title":"Hybrid insulin receptors. Molecular mechanisms of negative-dominant mutations in receptor-mediated insulin resistance","volume":"13","author":"Whittaker J","year":"1990","unstructured":"Whittaker J, Soos MA, Siddle K. Hybrid insulin receptors. Molecular mechanisms of negative-dominant mutations in receptor-mediated insulin resistance. Diabetes Care. 1990;13(6):576\u201381.","journal-title":"Diabetes Care"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.1016\/S0021-9258(18)42456-8","article-title":"Substitution of isoleucine for methionine at position 1153 in the beta-subunit of the human insulin receptor. A mutation that impairs receptor tyrosine kinase activity, receptor endocytosis, and insulin action","volume":"267","author":"Cama A","year":"1992","unstructured":"Cama A, Quon MJ, de la Luz Sierra M, Taylor SI. Substitution of isoleucine for methionine at position 1153 in the beta-subunit of the human insulin receptor. A mutation that impairs receptor tyrosine kinase activity, receptor endocytosis, and insulin action. J Biol Chem. 1992;267(12):8383\u20139.","journal-title":"J Biol Chem"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1073\/pnas.88.1.214","article-title":"Transdominant inhibition of tyrosine kinase activity in mutant insulin\/insulin-like growth factor I hybrid receptors","volume":"88","author":"Treadway JL","year":"1991","unstructured":"Treadway JL, Morrison BD, Soos MA, Siddle K, Olefsky J, Ullrich A, et al. Transdominant inhibition of tyrosine kinase activity in mutant insulin\/insulin-like growth factor I hybrid receptors. Proc Natl Acad Sci USA. 1991;88(1):214\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"27","key":"ref13","doi-asserted-by":"crossref","first-page":"19521","DOI":"10.1016\/S0021-9258(18)41806-6","article-title":"Transmembrane signaling by the human insulin receptor kinase. Relationship between intramolecular beta subunit trans- and cis-autophosphorylation and substrate kinase activation","volume":"267","author":"Frattali AL","year":"1992","unstructured":"Frattali AL, Treadway JL, Pessin JE. Transmembrane signaling by the human insulin receptor kinase. Relationship between intramolecular beta subunit trans- and cis-autophosphorylation and substrate kinase activation. J Biol Chem. 1992;267(27):19521\u20138.","journal-title":"J Biol Chem"},{"issue":"6","key":"ref14","first-page":"682","article-title":"Hybrid formation between endogenous mouse and transfected human tyrosine kinase-deficient (A\/K1018) insulin receptors leads to decreased insulin sensitivity in 3T3-L1 adipocytes","volume":"8","author":"Grako KA","year":"1994","unstructured":"Grako KA, McClain DA, Olefsky JM. Hybrid formation between endogenous mouse and transfected human tyrosine kinase-deficient (A\/K1018) insulin receptors leads to decreased insulin sensitivity in 3T3-L1 adipocytes. Molecular endocrinology (Baltimore, Md). 1994;8(6):682\u201392."},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/j.1460-2075.1994.tb06326.x","article-title":"Investigation of the mechanism of the dominant negative effect of mutations in the tyrosine kinase domain of the insulin receptor","volume":"13","author":"Levy-Toledano R","year":"1994","unstructured":"Levy-Toledano R, Caro LH, Accili D, Taylor SI. Investigation of the mechanism of the dominant negative effect of mutations in the tyrosine kinase domain of the insulin receptor. EMBO J. 1994;13(4):835\u201342.","journal-title":"EMBO J"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1042\/bj2630553","article-title":"Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors","volume":"263","author":"Soos MA","year":"1989","unstructured":"Soos MA, Siddle K. Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors. Biochem J. 1989;263(2):553\u201363.","journal-title":"Biochem J"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/BF00274534","article-title":"Individuals with only one allele for a functional insulin receptor have a tendency to hyperinsulinaemia but not to hyperglycaemia","volume":"32","author":"Lekanne Deprez RH","year":"1989","unstructured":"Lekanne Deprez RH, van Potter BJ, van der Zon GC, M\u00f6ller W, Lindhout D, Klinkhamer MP, et al. Individuals with only one allele for a functional insulin receptor have a tendency to hyperinsulinaemia but not to hyperglycaemia. Diabetologia. 1989;32(10):740\u20134.","journal-title":"Diabetologia"},{"issue":"12","key":"ref18","first-page":"3662","article-title":"Insulin resistance associated with substitution of histidine for arginine 252 in the alpha-subunit of the human insulin receptor: trial of insulin-like growth factor I injection therapy to enhance insulin sensitivity","volume":"80","author":"Nakashima N","year":"1995","unstructured":"Nakashima N, Umeda F, Yanase T, Nawata H. Insulin resistance associated with substitution of histidine for arginine 252 in the alpha-subunit of the human insulin receptor: trial of insulin-like growth factor I injection therapy to enhance insulin sensitivity. J Clin Endocrinol Metab. 1995;80(12):3662\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1507\/endocrj.K09E-339","article-title":"Phenotypical variety of insulin resistance in a family with a novel mutation of the insulin receptor gene","volume":"57","author":"Takahashi I","year":"2010","unstructured":"Takahashi I, Yamada Y, Kadowaki H, Horikoshi M, Kadowaki T, Narita T, et al. Phenotypical variety of insulin resistance in a family with a novel mutation of the insulin receptor gene. Endocr J. 2010;57(6):509\u201316.","journal-title":"Endocr J"},{"issue":"5","key":"ref20","first-page":"1153","article-title":"Deletion of exon 3 of the insulin receptor gene in a kindred with a familial form of insulin resistance","volume":"78","author":"Wertheimer E","year":"1994","unstructured":"Wertheimer E, Litvin Y, Ebstein RP, Bennet ER, Barbetti F, Accili D, et al. Deletion of exon 3 of the insulin receptor gene in a kindred with a familial form of insulin resistance. J Clin Endocrinol Metab. 1994;78(5):1153\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2337\/diab.46.11.1901","article-title":"Dominant transmission of insulin resistance in a type A family resulting from a heterozygous nonsense mutation in the insulin receptor gene and associated with decreased mRNA level and insulin binding sites","volume":"46","author":"Magr\u00e9 J","year":"1997","unstructured":"Magr\u00e9 J, Karayanni C, Hadjiathanasiou CG, Desbois-Mouthon C, Meier M, Vigouroux C, et al. Dominant transmission of insulin resistance in a type A family resulting from a heterozygous nonsense mutation in the insulin receptor gene and associated with decreased mRNA level and insulin binding sites. Diabetes. 1997;46(11):1901\u20133.","journal-title":"Diabetes"},{"key":"ref22","author":"Song Y","year":"2024","unstructured":"Song Y, Lei W, Huang Q, Zhang J, Zhang Q, Chen L et al. A New Heterozygous Variant of c.1225_1227delTTC (p.Phe409del) in Insulin Receptor Gene Associated with Severe Insulin Resistance and Hyperandrogenemia in an Adolescent Female with Type A Severe Insulin Resistance Syndrome. Diabetes, metabolic syndrome and obesity: targets and therapy. 2024;17:4389-96."},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"e12619","DOI":"10.1111\/cob.12619","article-title":"Can obesity exacerbate hyperinsulinaemia in the presence of the mutation of an insulin receptor gene?","volume":"13","author":"Calcaterra V","year":"2023","unstructured":"Calcaterra V, Zuccotti G, Mari A, Iafusco F, Maione G, Iafusco D, et al. Can obesity exacerbate hyperinsulinaemia in the presence of the mutation of an insulin receptor gene? Clin Obes. 2023;13(6):e12619.","journal-title":"Clin Obes"},{"issue":"8699","key":"ref24","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0140-6736(90)92695-E","article-title":"Insulin-resistant diabetes associated with partial deletion of insulin-receptor gene","volume":"335","author":"Shimada F","year":"1990","unstructured":"Shimada F, Taira M, Suzuki Y, Hashimoto N, Nozaki O, Taira M, et al. Insulin-resistant diabetes associated with partial deletion of insulin-receptor gene. Lancet (London England). 1990;335(8699):1179\u201381.","journal-title":"Lancet (London England)"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"101404","DOI":"10.1016\/j.gim.2025.101404","article-title":"Insulin receptor variants: Extending the traditional Mendelian spectrum","volume":"27","author":"Collin-Chavagnac D","year":"2025","unstructured":"Collin-Chavagnac D, Saint-Martin C, Bedidi L, Lebreton L, Aslanzadeh V, Vigouroux C, et al. Insulin receptor variants: Extending the traditional Mendelian spectrum. Genet medicine: official J Am Coll Med Genet. 2025;27(6):101404.","journal-title":"Genet medicine: official J Am Coll Med Genet"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1210\/clinem\/dgab877","article-title":"Identification of Rare Loss-of-Function Genetic Variation Regulating Body Fat Distribution","volume":"107","author":"Koprulu M","year":"2022","unstructured":"Koprulu M, Zhao Y, Wheeler E, Dong L, Rocha N, Li C, et al. Identification of Rare Loss-of-Function Genetic Variation Regulating Body Fat Distribution. J Clin Endocrinol Metab. 2022;107(4):1065\u201377.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1210\/clinem\/dgab275","article-title":"Ovarian Hyperandrogenism and Response to Gonadotropin-releasing Hormone Analogues in Primary Severe Insulin Resistance","volume":"106","author":"Huang-Doran I","year":"2021","unstructured":"Huang-Doran I, Kinzer AB, Jimenez-Linan M, Thackray K, Harris J, Adams CL, et al. Ovarian Hyperandrogenism and Response to Gonadotropin-releasing Hormone Analogues in Primary Severe Insulin Resistance. J Clin Endocrinol Metab. 2021;106(8):2367\u201383.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10545","key":"ref28","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0140-6736(26)00717-8","article-title":"Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process","volume":"407","author":"Teede HJ","year":"2026","unstructured":"Teede HJ, Khomami MB, Morman R, Laven JSE, Joham AE, Costello MF, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026;407(10545):2329\u201339.","journal-title":"Lancet"},{"issue":"2","key":"ref29","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple RK","year":"2009","unstructured":"Semple RK, Sleigh A, Murgatroyd PR, Adams CA, Bluck L, Jackson S, et al. Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Investig. 2009;119(2):315\u201322.","journal-title":"J Clin Investig"},{"issue":"14","key":"ref30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197604012941401","article-title":"The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man","volume":"294","author":"Kahn CR","year":"1976","unstructured":"Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, et al. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med. 1976;294(14):739\u201345.","journal-title":"N Engl J Med"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.2337\/diabetes.53.6.1592","article-title":"A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene","volume":"53","author":"H\u00f8jlund K","year":"2004","unstructured":"H\u00f8jlund K, Hansen T, Lajer M, Henriksen JE, Levin K, Lindholm J, et al. A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene. Diabetes. 2004;53(6):1592\u20138.","journal-title":"Diabetes"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1507\/endocrj.EJ14-0547","article-title":"Hyperinsulinemic hypoglycemia syndrome associated with mutations in the human insulin receptor gene: report of two cases","volume":"62","author":"Kuroda Y","year":"2015","unstructured":"Kuroda Y, Iwahashi H, Mineo I, Fukui K, Fukuhara A, Iwamoto R, et al. Hyperinsulinemic hypoglycemia syndrome associated with mutations in the human insulin receptor gene: report of two cases. Endocr J. 2015;62(4):353\u201362.","journal-title":"Endocr J"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.diabet.2016.07.001","article-title":"Hypoglycaemia revealing heterozygous insulin receptor mutations","volume":"43","author":"Preumont V","year":"2017","unstructured":"Preumont V, Feincoeur C, Lascols O, Courtillot C, Touraine P, Maiter D, et al. Hypoglycaemia revealing heterozygous insulin receptor mutations. Diabetes Metab. 2017;43(1):95\u20136.","journal-title":"Diabetes Metab"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/pedi.12632","article-title":"Severe insulin resistance in disguise: A familial case of reactive hypoglycemia associated with a novel heterozygous INSR mutation","volume":"19","author":"Innaurato S","year":"2018","unstructured":"Innaurato S, Brierley GV, Grasso V, Massimi A, Gaudino R, Sileno S, et al. Severe insulin resistance in disguise: A familial case of reactive hypoglycemia associated with a novel heterozygous INSR mutation. Pediatr Diabetes. 2018;19(4):670\u20134.","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000510462","article-title":"Unusual Glycemic Presentations in a Child with a Novel Heterozygous Intragenic INSR Deletion","volume":"93","author":"Verdecchia F","year":"2020","unstructured":"Verdecchia F, Akcan N, Dastamani A, Morgan K, Semple RK, Shah P. Unusual Glycemic Presentations in a Child with a Novel Heterozygous Intragenic INSR Deletion. Hormone Res paediatrics. 2020;93(6):396\u2013401.","journal-title":"Hormone Res paediatrics"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4274\/jcrpe.galenos.2019.2019.0106","volume":"12","author":"Sethi A","year":"2020","unstructured":"Sethi A, Foulds N, Ehtisham S, Ahmed SH, Houghton J, Colclough K, et al. Heterozygous Insulin Receptor J Clin Res Pediatr Endocrinol. 2020;12(4):420\u20136.","journal-title":"Heterozygous Insulin Receptor J Clin Res Pediatr Endocrinol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1493280","DOI":"10.3389\/fped.2024.1493280","article-title":"Case Report: Functional characterization of a missense variant in","volume":"12","author":"Guzman H","year":"2024","unstructured":"Guzman H, Mitteer LM, Chen P, Juliana CA, Boodhansingh K, Lord K, et al. Case Report: Functional characterization of a missense variant in. Front Pead. 2024;12:1493280.","journal-title":"Front Pead"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"luae221","DOI":"10.1210\/jcemcr\/luae221","article-title":"Hyperinsulinemic Hypoglycemia in a Patient With a Mutation in the Insulin Receptor","volume":"2","author":"Imamovic M","year":"2024","unstructured":"Imamovic M, V\u00e5gberg M, Cederquist K, Dahlqvist P. Hyperinsulinemic Hypoglycemia in a Patient With a Mutation in the Insulin Receptor. JCEM case Rep. 2024;2(12):luae221.","journal-title":"JCEM case Rep"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"luaf247","DOI":"10.1210\/jcemcr\/luaf247","article-title":"Postprandial Hypoglycemia Associated With","volume":"3","author":"Delacruz L","year":"2025","unstructured":"Delacruz L, Adamczak LJ, Astapova O. Postprandial Hypoglycemia Associated With. JCEM case Rep. 2025;3(12):luaf247.","journal-title":"JCEM case Rep"},{"key":"ref40","unstructured":"https:\/\/studies.epi.ims.cam.ac.uk\/fenland"},{"issue":"7809","key":"ref41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski KJ","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434\u201343.","journal-title":"Nature"},{"issue":"11","key":"ref42","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/s41588-019-0517-5","article-title":"The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy","volume":"51","author":"Lindeboom RGH","year":"2019","unstructured":"Lindeboom RGH, Vermeulen M, Lehner B, Supek F. The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy. Nat Genet. 2019;51(11):1645\u201351.","journal-title":"Nat Genet"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting Splicing from Primary Sequence with Deep Learning","volume":"176","author":"Jaganathan K","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting Splicing from Primary Sequence with Deep Learning. Cell. 2019;176(3):535\u2013e4824.","journal-title":"Cell"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"9143","DOI":"10.1038\/s41467-025-64178-4","article-title":"Deep mutational scanning of the human insulin receptor ectodomain to inform precision therapy for insulin resistance","volume":"16","author":"Aslanzadeh V","year":"2025","unstructured":"Aslanzadeh V, Brierley GV, Kumar R, \u00c7ubuk H, Vigouroux C, Matreyek KA, et al. Deep mutational scanning of the human insulin receptor ectodomain to inform precision therapy for insulin resistance. Nat Commun. 2025;16(1):9143.","journal-title":"Nat Commun"},{"issue":"9946","key":"ref45","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(14)60932-6","article-title":"International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project","volume":"384","author":"Villar J","year":"2014","unstructured":"Villar J, Cheikh Ismail L, Victora CG, Ohuma EO, Bertino E, Altman DG, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet (London England). 2014;384(9946):857\u201368.","journal-title":"Lancet (London England)"},{"key":"ref46","first-page":"63","volume-title":"Construction of LMS parameters for the Centers for Disease Control and Prevention 2000 growth charts","author":"Flegal KMC","year":"2013","unstructured":"Flegal KMC. T.J. Construction of LMS parameters for the Centers for Disease Control and Prevention 2000 growth charts. National health statistics reports; Hyattsville, MD: National Center for Health Statistics; 2013. p. 63."},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jn\/nxz263","article-title":"A Combination of Metabolites Predicts Adherence to the Mediterranean Diet Pattern and Its Associations with Insulin Sensitivity and Lipid Homeostasis in the General Population: The Fenland Study, United Kingdom","volume":"150","author":"Tong TYN","year":"2020","unstructured":"Tong TYN, Koulman A, Griffin JL, Wareham NJ, Forouhi NG, Imamura F. A Combination of Metabolites Predicts Adherence to the Mediterranean Diet Pattern and Its Associations with Insulin Sensitivity and Lipid Homeostasis in the General Population: The Fenland Study, United Kingdom. J Nutr. 2020;150(3):568\u201378.","journal-title":"J Nutr"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl Variant Effect Predictor","volume":"17","author":"McLaren W","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17(1):122.","journal-title":"Genome Biol"},{"key":"ref49","author":"Peplies J","year":"2005","unstructured":"Peplies J, Jim\u00e9nez-Pav\u00f3n D, Savva SC, Buck C, G\u00fcnther K, Fraterman A et al. Percentiles of fasting serum insulin, glucose, HbA1c and HOMA-IR in pre-pubertal normal weight European children from the IDEFICS cohort. International journal of obesity (2005). 2014;38 Suppl 2:S39-47."},{"key":"ref50","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. National Health and Nutrition Examination Survey Data, 2011\u20132018. Hyattsville, MD: U.S. Department of Health and Human Services. Available at: https:\/\/www.cdc.gov\/nchs\/nhanes\/"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"100652","DOI":"10.1016\/j.lanepe.2023.100652","article-title":"Fasting indices of glucose-insulin-metabolism across life span and prediction of glycemic deterioration in children with obesity from new diagnostic cut-offs","volume":"30","author":"Hammel MC","year":"2023","unstructured":"Hammel MC, Stein R, Kratzsch J, Vogel M, Eckert AJ, Triatin RD, et al. Fasting indices of glucose-insulin-metabolism across life span and prediction of glycemic deterioration in children with obesity from new diagnostic cut-offs. Lancet Reg health Europe. 2023;30:100652.","journal-title":"Lancet Reg health Europe"},{"key":"ref52","article-title":"Pediatric Reference Values for Insulin from oGTT and Prevalence of Hyperinsulinemia in Obese Children","volume":"82","author":"Roth CLE","year":"2014","unstructured":"Roth CLE, Reinehr C, Wunsch T, Hampe R. C.S. Pediatric Reference Values for Insulin from oGTT and Prevalence of Hyperinsulinemia in Obese Children. ESPE Abstracts 2014;82:FC12.4.","journal-title":"ESPE Abstracts"},{"issue":"7","key":"ref53","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00125-018-4606-2","article-title":"Evaluation of anti-insulin receptor antibodies as potential novel therapies for human insulin receptoropathy using cell culture models","volume":"61","author":"Brierley GV","year":"2018","unstructured":"Brierley GV, Siddle K, Semple RK. Evaluation of anti-insulin receptor antibodies as potential novel therapies for human insulin receptoropathy using cell culture models. Diabetologia. 2018;61(7):1662\u201375.","journal-title":"Diabetologia"},{"issue":"7993","key":"ref54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen S","year":"2024","unstructured":"Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature. 2024;625(7993):92\u2013100.","journal-title":"Nature"},{"issue":"2","key":"ref55","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0014-5793(94)00876-0","article-title":"Functional properties of a heterozygous mutation (Arg1174\u2013>Gln) in the tyrosine kinase domain of the insulin receptor from a type A insulin resistant patient","volume":"351","author":"Moritz W","year":"1994","unstructured":"Moritz W, Froesch ER, B\u00f6ni-Schnetzler M. Functional properties of a heterozygous mutation (Arg1174\u2013>Gln) in the tyrosine kinase domain of the insulin receptor from a type A insulin resistant patient. FEBS Lett. 1994;351(2):276\u201380.","journal-title":"FEBS Lett"},{"issue":"12","key":"ref56","doi-asserted-by":"crossref","first-page":"7134","DOI":"10.1074\/jbc.271.12.7134","article-title":"Two naturally occurring mutant insulin receptors phosphorylate insulin receptor substrate-1 (IRS-1) but fail to mediate the biological effects of insulin. Evidence that IRS-1 phosphorylation is not sufficient for normal insulin action","volume":"271","author":"Krook A","year":"1996","unstructured":"Krook A, Moller DE, Dib K, O'Rahilly S. Two naturally occurring mutant insulin receptors phosphorylate insulin receptor substrate-1 (IRS-1) but fail to mediate the biological effects of insulin. Evidence that IRS-1 phosphorylation is not sufficient for normal insulin action. J Biol Chem. 1996;271(12):7134\u201340.","journal-title":"J Biol Chem"},{"issue":"8","key":"ref57","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.2337\/diab.47.8.1362","article-title":"Multiple molecular mechanisms of insulin receptor dysfunction in a patient with Donohue syndrome","volume":"47","author":"Whitehead JP","year":"1998","unstructured":"Whitehead JP, Soos MA, Jackson R, Tasic V, Kocova M, O'Rahilly S. Multiple molecular mechanisms of insulin receptor dysfunction in a patient with Donohue syndrome. Diabetes. 1998;47(8):1362\u20134.","journal-title":"Diabetes"},{"issue":"7","key":"ref58","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2337\/diabetes.49.7.1264","article-title":"Naturally occurring amino acid substitutions at Arg1174 in the human insulin receptor result in differential effects on receptor biosynthesis and hybrid formation, leading to discordant clinical phenotypes","volume":"49","author":"Rau H","year":"2000","unstructured":"Rau H, Kocova M, O'Rahilly S, Whitehead JP. Naturally occurring amino acid substitutions at Arg1174 in the human insulin receptor result in differential effects on receptor biosynthesis and hybrid formation, leading to discordant clinical phenotypes. Diabetes. 2000;49(7):1264\u20138.","journal-title":"Diabetes"},{"issue":"48","key":"ref59","doi-asserted-by":"crossref","first-page":"30208","DOI":"10.1074\/jbc.272.48.30208","article-title":"Two naturally occurring insulin receptor tyrosine kinase domain mutants provide evidence that phosphoinositide 3-kinase activation alone is not sufficient for the mediation of insulin's metabolic and mitogenic effects","volume":"272","author":"Krook A","year":"1997","unstructured":"Krook A, Whitehead JP, Dobson SP, Griffiths MR, Ouwens M, Baker C, et al. Two naturally occurring insulin receptor tyrosine kinase domain mutants provide evidence that phosphoinositide 3-kinase activation alone is not sufficient for the mediation of insulin's metabolic and mitogenic effects. J Biol Chem. 1997;272(48):30208\u201314.","journal-title":"J Biol Chem"},{"issue":"15","key":"ref60","doi-asserted-by":"crossref","first-page":"11349","DOI":"10.1016\/S0021-9258(19)78131-9","article-title":"Substitution of glutamine for arginine 1131. A newly identified mutation in the catalytic loop of the tyrosine kinase domain of the human insulin receptor","volume":"269","author":"Kishimoto M","year":"1994","unstructured":"Kishimoto M, Hashiramoto M, Yonezawa K, Shii K, Kazumi T, Kasuga M. Substitution of glutamine for arginine 1131. A newly identified mutation in the catalytic loop of the tyrosine kinase domain of the human insulin receptor. J Biol Chem. 1994;269(15):11349\u201355.","journal-title":"J Biol Chem"},{"issue":"8","key":"ref61","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/pedi.12508","article-title":"Molecular mechanisms of insulin resistance in 2 cases of primary insulin receptor defect-associated diseases","volume":"18","author":"Tsuji-Hosokawa A","year":"2017","unstructured":"Tsuji-Hosokawa A, Takasawa K, Nomura R, Miyakawa Y, Numakura C, Hijikata A, et al. Molecular mechanisms of insulin resistance in 2 cases of primary insulin receptor defect-associated diseases. Pediatr Diabetes. 2017;18(8):917\u201324.","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"ref62","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1210\/jcem-73-4-894","article-title":"A mutation in the tyrosine kinase domain of the insulin receptor associated with insulin resistance in an obese woman","volume":"73","author":"Cama A","year":"1991","unstructured":"Cama A, de la Luz Sierra M, Ottini L, Kadowaki T, Gorden P, Imperato-McGinley J, et al. A mutation in the tyrosine kinase domain of the insulin receptor associated with insulin resistance in an obese woman. J Clin Endocrinol Metab. 1991;73(4):894\u2013901.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"ref63","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1073\/pnas.91.12.5587","article-title":"Tyrosine kinase-deficient mutant human insulin receptors (Met1153\u2013>Ile) overexpressed in transfected rat adipose cells fail to mediate translocation of epitope-tagged GLUT4","volume":"91","author":"Quon MJ","year":"1994","unstructured":"Quon MJ, Guerre-Millo M, Zarnowski MJ, Butte AJ, Em M, Cushman SW, et al. Tyrosine kinase-deficient mutant human insulin receptors (Met1153\u2013>Ile) overexpressed in transfected rat adipose cells fail to mediate translocation of epitope-tagged GLUT4. Proc Natl Acad Sci USA. 1994;91(12):5587\u201391.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"ref64","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/BF00400255","article-title":"Abnormal messenger ribonucleic acid (mRNA) transcribed from a mutant insulin receptor gene in a patient with type A insulin resistance","volume":"35","author":"Shimada F","year":"1992","unstructured":"Shimada F, Suzuki Y, Taira M, Hashimoto N, Nozaki O, Makino H, et al. Abnormal messenger ribonucleic acid (mRNA) transcribed from a mutant insulin receptor gene in a patient with type A insulin resistance. Diabetologia. 1992;35(7):639\u201344.","journal-title":"Diabetologia"},{"issue":"1","key":"ref65","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12966-019-0882-6","article-title":"Descriptive epidemiology of physical activity energy expenditure in UK adults (The Fenland study)","volume":"16","author":"Lindsay T","year":"2019","unstructured":"Lindsay T, Westgate K, Wijndaele K, Hollidge S, Kerrison N, Forouhi N, et al. Descriptive epidemiology of physical activity energy expenditure in UK adults (The Fenland study). Int J Behav Nutr Phys Act. 2019;16(1):126.","journal-title":"Int J Behav Nutr Phys Act"},{"key":"ref66","article-title":"Pre-gestational diabetes in a young woman with a pathogenic INSR missense mutation, p.(Met1180Lys)","author":"Prehn EL","unstructured":"Prehn EL, Crowley M, Fennell D, Kinsley BT, Colclough K, Byrne MM. Pre-gestational diabetes in a young woman with a pathogenic INSR missense mutation, p.(Met1180Lys). Endocrinology, diabetes & metabolism case reports. 2025;2025(1)."},{"issue":"7","key":"ref67","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1172\/JCI135431","article-title":"Free fatty acid processing diverges in human pathologic insulin resistance conditions","volume":"130","author":"Sekizkardes H","year":"2020","unstructured":"Sekizkardes H, Chung ST, Chacko S, Haymond MW, Startzell M, Walter M, et al. Free fatty acid processing diverges in human pathologic insulin resistance conditions. J Clin Investig. 2020;130(7):3592\u2013602.","journal-title":"J Clin Investig"},{"issue":"3","key":"ref68","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2337\/diab.43.3.357","article-title":"Molecular scanning of the insulin receptor gene in syndromes of insulin resistance","volume":"43","author":"Krook A","year":"1994","unstructured":"Krook A, Kumar S, Laing I, Boulton AJ, Wass JA, O'Rahilly S. Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes. 1994;43(3):357\u201368.","journal-title":"Diabetes"},{"issue":"11","key":"ref69","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.2337\/dc07-1342","article-title":"Elevated plasma adiponectin and leptin levels in sisters with genetically defective insulin receptors","volume":"30","author":"Hattori Y","year":"2007","unstructured":"Hattori Y, Hirama N, Suzuki K, Hattori S, Kasai K. Elevated plasma adiponectin and leptin levels in sisters with genetically defective insulin receptors. Diabetes Care. 2007;30(11):e109.","journal-title":"Diabetes Care"},{"issue":"5","key":"ref70","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2337\/dc07-2194","article-title":"Plasma adiponectin as a marker of insulin receptor dysfunction: clinical utility in severe insulin resistance","volume":"31","author":"Semple RK","year":"2008","unstructured":"Semple RK, Cochran EK, Soos MA, Burling KA, Savage DB, Gorden P, et al. Plasma adiponectin as a marker of insulin receptor dysfunction: clinical utility in severe insulin resistance. Diabetes Care. 2008;31(5):977\u20139.","journal-title":"Diabetes Care"},{"issue":"6","key":"ref71","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.2337\/db06-1665","article-title":"Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies","volume":"56","author":"Semple RK","year":"2007","unstructured":"Semple RK, Halberg NH, Burling K, Soos MA, Schraw T, Luan J, et al. Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes. 2007;56(6):1712\u20137.","journal-title":"Diabetes"},{"issue":"8","key":"ref72","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1210\/jc.2006-0166","article-title":"Elevated plasma adiponectin in humans with genetically defective insulin receptors","volume":"91","author":"Semple RK","year":"2006","unstructured":"Semple RK, Soos MA, Luan J, Mitchell CS, Wilson JC, Gurnell M, et al. Elevated plasma adiponectin in humans with genetically defective insulin receptors. J Clin Endocrinol Metab. 2006;91(8):3219\u201323.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"ref73","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/edrv-8-2-132","article-title":"The gonadotropic function of insulin","volume":"8","author":"Poretsky L","year":"1987","unstructured":"Poretsky L, Kalin MF. The gonadotropic function of insulin. Endocr Rev. 1987;8(2):132\u201341.","journal-title":"Endocr Rev"},{"issue":"8","key":"ref74","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1172\/JCI41069","article-title":"Divergent roles of growth factors in the GnRH regulation of puberty in mice","volume":"120","author":"Divall SA","year":"2010","unstructured":"Divall SA, Williams TR, Carver SE, Koch L, Br\u00fcning JC, Kahn CR, et al. Divergent roles of growth factors in the GnRH regulation of puberty in mice. J Clin Investig. 2010;120(8):2900\u20139.","journal-title":"J Clin Investig"},{"key":"ref75","first-page":"100965","article-title":"A novel nonsense mutation in the insulin receptor gene in a patient with HAIR-AN syndrome and endometrial cancer","volume":"35","author":"Cuenca D","year":"2023","unstructured":"Cuenca D, Ventura-Gallegos JL, Almeda-Valdes P, Tusi\u00e9-Luna MT, Reza-Albarran A, Ventura-Ayala L, et al. A novel nonsense mutation in the insulin receptor gene in a patient with HAIR-AN syndrome and endometrial cancer. Mol Genet metabolism Rep. 2023;35:100965.","journal-title":"Mol Genet metabolism Rep"},{"issue":"9","key":"ref76","first-page":"588","article-title":"INSR gene mutation. Insulin resistance with low prevalence in pediatrics. A case review","volume":"66","author":"Ariza Jim\u00e9nez AB","year":"2019","unstructured":"Ariza Jim\u00e9nez AB, L\u00f3pez Siguero JP, Mart\u00ednez Aedo Ollero MJ, Del Fuente P, Leiva Gea A. INSR gene mutation. Insulin resistance with low prevalence in pediatrics. A case review. Endocrinologia diabetes y nutricion. 2019;66(9):588\u20139.","journal-title":"Endocrinologia diabetes y nutricion"},{"issue":"10285","key":"ref77","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby S","year":"2021","unstructured":"Quenby S, Gallos ID, Dhillon-Smith RK, Podesek M, Stephenson MD, Fisher J, et al. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet (London England). 2021;397(10285):1658\u201367.","journal-title":"Lancet (London England)"},{"issue":"10019","key":"ref78","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0140-6736(15)01020-X","article-title":"Stillbirths: recall to action in high-income countries","volume":"387","author":"Flenady V","year":"2016","unstructured":"Flenady V, Wojcieszek AM, Middleton P, Ellwood D, Erwich JJ, Coory M, et al. Stillbirths: recall to action in high-income countries. Lancet (London England). 2016;387(10019):691\u2013702.","journal-title":"Lancet (London England)"},{"issue":"10409","key":"ref79","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(23)00878-4","article-title":"National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis","volume":"402","author":"Ohuma EO","year":"2023","unstructured":"Ohuma EO, Moller AB, Bradley E, Chakwera S, Hussain-Alkhateeb L, Lewin A, et al. National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis. Lancet (London England). 2023;402(10409):1261\u201371.","journal-title":"Lancet (London England)"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.diabres.2017.03.030","article-title":"Prevalence of gestational diabetes mellitus in Europe: A meta-analysis","volume":"129","author":"Eades CE","year":"2017","unstructured":"Eades CE, Cameron DM, Evans JMM. Prevalence of gestational diabetes mellitus in Europe: A meta-analysis. Diabetes Res Clin Pract. 2017;129:173\u201381.","journal-title":"Diabetes Res Clin Pract"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"109050","DOI":"10.1016\/j.diabres.2021.109050","article-title":"IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group's Criteria","volume":"183","author":"Wang H","year":"2022","unstructured":"Wang H, Li N, Chivese T, Werfalli M, Sun H, Yuen L, et al. IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group's Criteria. Diabetes Res Clin Pract. 2022;183:109050.","journal-title":"Diabetes Res Clin Pract"},{"issue":"16","key":"ref82","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1504909","article-title":"Neonatal Glycemia and Neurodevelopmental Outcomes at 2 Years","volume":"373","author":"McKinlay CJ","year":"2015","unstructured":"McKinlay CJ, Alsweiler JM, Ansell JM, Anstice NS, Chase JG, Gamble GD, et al. Neonatal Glycemia and Neurodevelopmental Outcomes at 2 Years. N Engl J Med. 2015;373(16):1507\u201318.","journal-title":"N Engl J Med"},{"issue":"1","key":"ref83","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40842-024-00166-9","article-title":"Case report: Glycaemic management and pregnancy outcomes in a woman with an insulin receptor mutation, p.Met1180Lys","volume":"10","author":"Crowley MT","year":"2024","unstructured":"Crowley MT, Goulden E, Sanchez-Lechuga B, Fleming A, Kennelly M, McDonnell C, et al. Case report: Glycaemic management and pregnancy outcomes in a woman with an insulin receptor mutation, p.Met1180Lys. Clin diabetes Endocrinol. 2024;10(1):5.","journal-title":"Clin diabetes Endocrinol"},{"issue":"6","key":"ref84","first-page":"1533","article-title":"Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance","volume":"76","author":"Flier JS","year":"1993","unstructured":"Flier JS, Moller DE, Moses AC, O'Rahilly S, Chaiken RL, Grigorescu F, et al. Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance. J Clin Endocrinol Metab. 1993;76(6):1533\u201341.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"ref85","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI119884","article-title":"Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly. A disorder characterized by selective postreceptor insulin resistance","volume":"101","author":"Dib K","year":"1998","unstructured":"Dib K, Whitehead JP, Humphreys PJ, Soos MA, Baynes KC, Kumar S, et al. Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly. A disorder characterized by selective postreceptor insulin resistance. J Clin Investig. 1998;101(5):1111\u201320.","journal-title":"J Clin Investig"},{"issue":"2","key":"ref86","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/jcem-69-2-329","article-title":"Acromegaloid patients with type A insulin resistance: parallel defects in insulin and insulin-like growth factor-I receptors and biological responses in cultured fibroblasts","volume":"69","author":"Low L","year":"1989","unstructured":"Low L, Chernausek SD, Sperling MA. Acromegaloid patients with type A insulin resistance: parallel defects in insulin and insulin-like growth factor-I receptors and biological responses in cultured fibroblasts. J Clin Endocrinol Metab. 1989;69(2):329\u201337.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"ref87","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/s-0029-1212090","article-title":"Insulin-mediated pseudoacromegaly in a patient with severe insulin resistance: association of defective insulin-stimulated glucose transport with impaired phosphatidylinositol 3-kinase activity in fibroblasts. Experimental and clinical endocrinology & diabetes: official journal","volume":"107","author":"Kausch C","year":"1999","unstructured":"Kausch C, Bergemann C, Hamann A, Matthaei S. Insulin-mediated pseudoacromegaly in a patient with severe insulin resistance: association of defective insulin-stimulated glucose transport with impaired phosphatidylinositol 3-kinase activity in fibroblasts. Experimental and clinical endocrinology & diabetes: official journal. German Soc Endocrinol [and] German Diabetes Association. 1999;107(2):148\u201354.","journal-title":"German Soc Endocrinol [and] German Diabetes Association"},{"issue":"12","key":"ref88","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1210\/jc.2019-00849","article-title":"Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy","volume":"104","author":"J\u00e9ru I","year":"2019","unstructured":"J\u00e9ru I, Vantyghem MC, Bismuth E, Cervera P, Barraud S, Group PL-S, et al. Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy. J Clin Endocrinol Metab. 2019;104(12):6025\u201332.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"ref89","first-page":"3465","article-title":"Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly","volume":"81","author":"Kumar S","year":"1996","unstructured":"Kumar S, Durrington PN, O'Rahilly S, Laing I, Humphreys PJ, Olukoga AO, et al. Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly. J Clin Endocrinol Metab. 1996;81(10):3465\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref90","first-page":"73","article-title":"Identification and Characterisation of a Novel Pathogenic Mutation in the Human Lipodystrophy Gene AGPAT2: C48R: A Novel Mutation in AGPAT2","volume":"9","author":"Ramanathan N","year":"2013","unstructured":"Ramanathan N, Ahmed M, Raffan E, Stewart CL, O'Rahilly S, Semple RK, et al. Identification and Characterisation of a Novel Pathogenic Mutation in the Human Lipodystrophy Gene AGPAT2: C48R: A Novel Mutation in AGPAT2. JIMD Rep. 2013;9:73\u201380.","journal-title":"JIMD Rep"},{"issue":"11","key":"ref91","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41568-020-0295-5","article-title":"Hyperinsulinaemia in cancer","volume":"20","author":"Gallagher EJ","year":"2020","unstructured":"Gallagher EJ, LeRoith D. Hyperinsulinaemia in cancer. Nat Rev Cancer. 2020;20(11):629\u201344.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"ref92","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2337\/diab.41.11.1473","article-title":"Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene","volume":"41","author":"Taylor SI","year":"1992","unstructured":"Taylor SI. Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes. 1992;41(11):1473\u201390.","journal-title":"Diabetes"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-biochem-052521-033250","article-title":"The Activation Mechanism of the Insulin Receptor: A Structural Perspective","volume":"92","author":"Choi E","year":"2023","unstructured":"Choi E, Bai XC. The Activation Mechanism of the Insulin Receptor: A Structural Perspective. Annu Rev Biochem. 2023;92:247\u201372.","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"ref94","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41594-022-00750-6","article-title":"Synergistic activation of the insulin receptor via two distinct sites","volume":"29","author":"Li J","year":"2022","unstructured":"Li J, Park J, Mayer JP, Webb KJ, Uchikawa E, Wu J, et al. Synergistic activation of the insulin receptor via two distinct sites. Nat Struct Mol Biol. 2022;29(4):357\u201368.","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"ref95","doi-asserted-by":"crossref","first-page":"167458","DOI":"10.1016\/j.jmb.2022.167458","article-title":"Structural Investigations of Full-Length Insulin Receptor Dynamics and Signalling","volume":"434","author":"Nielsen J","year":"2022","unstructured":"Nielsen J, Brandt J, Boesen T, Hummelsh\u00f8j T, Slaaby R, Schluckebier G, et al. Structural Investigations of Full-Length Insulin Receptor Dynamics and Signalling. J Mol Biol. 2022;434(5):167458.","journal-title":"J Mol Biol"},{"issue":"19","key":"ref96","doi-asserted-by":"crossref","first-page":"13719","DOI":"10.1016\/S0021-9258(18)42273-9","article-title":"The role of insulin receptor kinase domain autophosphorylation in receptor-mediated activities. Analysis with insulin and anti-receptor antibodies","volume":"267","author":"Wilden PA","year":"1992","unstructured":"Wilden PA, Siddle K, Haring E, Backer JM, White MF, Kahn CR. The role of insulin receptor kinase domain autophosphorylation in receptor-mediated activities. Analysis with insulin and anti-receptor antibodies. J Biol Chem. 1992;267(19):13719\u201327.","journal-title":"J Biol Chem"},{"issue":"23","key":"ref97","doi-asserted-by":"crossref","first-page":"16660","DOI":"10.1016\/S0021-9258(18)42053-4","article-title":"Insulin receptor kinase domain autophosphorylation regulates receptor enzymatic function","volume":"267","author":"Wilden PA","year":"1992","unstructured":"Wilden PA, Kahn CR, Siddle K, White MF. Insulin receptor kinase domain autophosphorylation regulates receptor enzymatic function. J Biol Chem. 1992;267(23):16660\u20138.","journal-title":"J Biol Chem"},{"issue":"4","key":"ref98","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0092-8674(00)81896-6","article-title":"Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles","volume":"88","author":"Br\u00fcning JC","year":"1997","unstructured":"Br\u00fcning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell. 1997;88(4):561\u201372.","journal-title":"Cell"},{"issue":"1","key":"ref99","first-page":"115","article-title":"Diazoxide-unresponsive Hyperinsulinemic Hypoglycaemia in a Preterm Infant with Heterozygous Insulin Receptor Gene Mutation","volume":"17","author":"Poon SWY","year":"2025","unstructured":"Poon SWY, Chung BHY, Wong MSC, Tsang AMC. Diazoxide-unresponsive Hyperinsulinemic Hypoglycaemia in a Preterm Infant with Heterozygous Insulin Receptor Gene Mutation. J Clin Res Pediatr Endocrinol. 2025;17(1):115\u20139.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1186\/1756-0500-7-804","article-title":"Poor pregnancy outcome after octreotide treatment during pregnancy for familial hyperinsulinemic hypoglycemia: a case report","volume":"7","author":"Skajaa GO","year":"2014","unstructured":"Skajaa GO, Mathiesen ER, Iyore E, Beck-Nielsen H, Jimenez-Solem E, Damm P. Poor pregnancy outcome after octreotide treatment during pregnancy for familial hyperinsulinemic hypoglycemia: a case report. BMC Res Notes. 2014;7:804.","journal-title":"BMC Res Notes"},{"issue":"9","key":"ref101","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/jdi.70105","article-title":"Management of pregnancy with metformin: Case reports for genetic insulin resistance syndrome and a literature review for gestational and type 2 diabetes","volume":"16","author":"Yoshimura K","year":"2025","unstructured":"Yoshimura K, Hirota Y, Hamaguchi T, Takeuchi T, Takayoshi T, Saito S, et al. Management of pregnancy with metformin: Case reports for genetic insulin resistance syndrome and a literature review for gestational and type 2 diabetes. J diabetes Invest. 2025;16(9):1663\u20139.","journal-title":"J diabetes Invest"},{"issue":"1","key":"ref102","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s43856-023-00368-9","article-title":"Genotype-stratified treatment for monogenic insulin resistance: a systematic review","volume":"3","author":"Semple RK","year":"2023","unstructured":"Semple RK, Patel KA, Auh S, Ada\/Easd P, Brown RJ. Genotype-stratified treatment for monogenic insulin resistance: a systematic review. Commun Med. 2023;3(1):134.","journal-title":"Commun Med"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10884175\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10884175\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T06:37:39Z","timestamp":1790577459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10884175\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":102,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10884175\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,9,28]]},"subtype":"preprint"}}